---
figid: PMC6520749__cancers-11-00465-g001
figlink: /pmc/articles/PMC6520749/figure/cancers-11-00465-f001/
number: Figure 1
caption: 'Schematic representation of the MAPK pathway in melanoma. Neuroblastoma
  RAS viral oncogene homolog (NRAS) and v-Raf murine sarcoma viral oncogene homolog
  B (BRAF) are the most commonly mutated oncogenes in melanoma and are strong activators
  of the MAPK pathway. Within this pathway negative feedback occurs towards mitogen-activated
  protein kinase kinase 1/2 (MEK1/2), BRAF and son of sevenless homolog (SOS). BRAF
  and MEK1/2 may by targeted by specific small molecule inhibitors. The activated
  MAPK pathway further activates transcription factors such as Ets-1, Elk-1, c-Fos,
  and CREB-1. Abbreviations: RTK, receptor tyrosine kinase; Shc, Src homology 2 domain
  containing adaptor protein; Grb-2, growth factor receptor bound protein 2; SOS,
  son of sevenless homolog. Ets-1, V-Ets avian erythroblastosis virus E26 oncogene;
  Elk-1, ETS-like gene 1; c-Fos, Fos proto-oncogene, AP-1 transcription factor subunit;
  CREB-1, CAMP responsive element binding protein 1.'
pmcid: PMC6520749
papertitle: Modelling of Protein Kinase Signaling Pathways in Melanoma and Other Cancers.
reftext: Manfred Kunz, et al. Cancers (Basel). 2019 Apr;11(4):465.
pmc_ranked_result_index: '154493'
pathway_score: 0.9457636
filename: cancers-11-00465-g001.jpg
figtitle: The MAPK pathway in melanoma
year: '2019'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6520749__cancers-11-00465-g001.html
  '@type': Dataset
  description: 'Schematic representation of the MAPK pathway in melanoma. Neuroblastoma
    RAS viral oncogene homolog (NRAS) and v-Raf murine sarcoma viral oncogene homolog
    B (BRAF) are the most commonly mutated oncogenes in melanoma and are strong activators
    of the MAPK pathway. Within this pathway negative feedback occurs towards mitogen-activated
    protein kinase kinase 1/2 (MEK1/2), BRAF and son of sevenless homolog (SOS). BRAF
    and MEK1/2 may by targeted by specific small molecule inhibitors. The activated
    MAPK pathway further activates transcription factors such as Ets-1, Elk-1, c-Fos,
    and CREB-1. Abbreviations: RTK, receptor tyrosine kinase; Shc, Src homology 2
    domain containing adaptor protein; Grb-2, growth factor receptor bound protein
    2; SOS, son of sevenless homolog. Ets-1, V-Ets avian erythroblastosis virus E26
    oncogene; Elk-1, ETS-like gene 1; c-Fos, Fos proto-oncogene, AP-1 transcription
    factor subunit; CREB-1, CAMP responsive element binding protein 1.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HRAS
  - KRAS
  - NRAS
  - BRAF
  - FOS
  - RAF1
  - CREB1
  - ELK1
  - MAPK3
  - GRB2
  - MAP2K1
  - MAP2K2
  - SOS1
  - SOS2
  - MAPK1
  - ETS1
  - Vemurafenib
  - Dabrafenib
  - Encorafenib
  - Cobimetinib
  - Trametinib
  - Binimetinib
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
genes:
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: B-Raf
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: c-Fos
  symbol: c-fos
  source: hgnc_alias_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: C-Raf
  symbol: c-Raf
  source: hgnc_alias_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: CREB-1
  symbol: CREB1
  source: hgnc_symbol
  hgnc_symbol: CREB1
  entrez: '1385'
- word: Elk-1
  symbol: ELK1
  source: hgnc_symbol
  hgnc_symbol: ELK1
  entrez: '2002'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Grb-2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Ets-1
  symbol: ETS-1
  source: hgnc_alias_symbol
  hgnc_symbol: ETS1
  entrez: '2113'
chemicals:
- word: Vemurafenib
  source: MESH
  identifier: C551177
- word: Dabrafenib
  source: MESH
  identifier: C561627
- word: Encorafenib
  source: ''
  identifier: ''
- word: Cobimetinib
  source: MESH
  identifier: C574276
- word: Trametinib
  source: MESH
  identifier: C560077
- word: Binimetinib
  source: MESH
  identifier: C581313
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
